Indeed, at the end of treatment period, the triplet combination treatment caused a more evident synergistic effect, with no palpable tumor present in 4 out of 10 mice engrafted with MC38-MR cells and 3 out of 10 mice engrafted with CT26-MR cells (Fig. 6a). This evidence concerns the gene NR3C2 and neoplasm.